• Alnylam Pharmaceuticals (ALNY) Reports Positive Clinical Results for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia More...

• Titan Pharmaceuticals (TTP) Announces Phase 3 Probuphine® Data Presentation at the American Society of Addiction Medicine (ASAM) 43rd Medical-Scientific Conference More...

• Boehringer Ingelheim Corporation Release: Pivotal Phase III Results for Afatinib* in Lung Cancer to be Presented at American Society of Clinical Oncology 2012 More...

• Genzyme Corporation (GENZ) Demonstrates Depth of MS Pipeline at AAN with Results from Multiple Sclerosis Phase lll Trials More...

• FDA Issues Warning Over Fentanyl Patches; Makers Include Mylan Inc. (MYL) and Watson Pharmaceuticals, Inc. (WPI) More...

• Incyte Corporation (INCY) Announces EU Regulatory Milestone for Ruxolitinib; Triggering a $40 Million Milestone Payment From Novartis AG (NVS) More...

• AMAG Pharmaceuticals, Inc. (AMAG) Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease More...

• Allos Therapeutics, Inc. (ALTH) Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN® in Europe More...

• Elan Corporation PLC (ELN), Scientists Chases After Alzheimer Prevention Drug More...

• Omega-3 Fatty Acids May Combat Smoking Harm, University of Athens Medical School Study More...

• Key Genes That Switch Off With Aging Highlighted as Potential Targets for Anti-Aging Therapies, King's College London Study More...

• Women With Heart Disease More Likely to Have Baby Girls, Tabriz University Study More...

• Insomnia Takes Toll on Tinnitus Patients, Henry Ford Hospital Study More...

• Merck KGaA (MKGAF.PK) CEO: We Must Cut Jobs, Reduce Costs More...

• Aspen Pharmacare Ltd. Buys GlaxoSmithKline (GSK) OTC Drug Brands for $263 Million More...

• Par Pharmaceutical Companies, Inc. (PRX) Buys Rights to Market, Distribute Generic Dexilant® in the U.S. More...

• BioTime (BTX) and Subsidiary LifeMap Sciences Announce Agreement to Acquire XenneX, Inc. More...

• Incyte Corporation (INCY) Announces EU Regulatory Milestone for Ruxolitinib; Triggering a $40 Million Milestone Payment From Novartis AG (NVS) More...

• Butamax and Fagen Announce Collaboration to Retrofit Ethanol Plants for Biobutanol Production More...

• IDEXX Laboratories, Inc. (IDXX) Release: PurinaCare® Announces Partners in Wellness for Veterinarians More...

• Eisai Inc. (ESALF.PK) Amends License Agreement With Teikoku Pharma For Aricept® Patch (Donepezil Transdermal System) More...

• University of Illinois at Urbana-Champaign Announces Licensing Agreement with Sigma-Aldrich Corporation (SIAL) to Provide Membrane Scaffold Proteins for Nanodisc Technology to the Research Community More...

• J. Erik Fyrwald to be President and Chief Executive Officer of Univar, John J. Zillmer to Become Executive Chairman ofUnivar and its Board of Directors More...

• Hologenix Completes Science Advisory Board More...

• Cannabis Science Inc. Signs Andrew Pitsicalis as International Brand and Licensing Director More...

• VIVUS, Inc. (VVUS) Appoints Ernest Mario, Ph.D. to the Board of Directors More...

• Cell Therapeutics, Inc. (CTIC) (CTI) Reports First Quarter Financial Results and Milestones More...

• Exelixis, Inc. (EXEL) Announces May 3rd Webcast of First Quarter 2012 Financial Results Conference Call More...

• Gilead Sciences, Inc. (GILD) to Release First Quarter 2012 Financial Results on Thursday, April 26, 2012 More...

• Human Genome Sciences, Inc. (HGSI) to Sponsor Conference Call to Discuss First Quarter 2012 Financial Results More...

• Momenta Pharmaceuticals, Inc. (MNTA) Announces Date of First Quarter 2012 Financial Results Conference Call More...

• Ameritox, Ltd. Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages More...